Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Stroke. 2016 May 10;47(6):1632–1639. doi: 10.1161/STROKEAHA.116.012701

Table 2.

Pooled estimates from meta-analysis of major outcomes

Outcome Number of animals
Control / Intervention
Pooled SMD
(95% CI)
P value
Lesion Size
Absolute Reduction 113 / 113 −3.3 (−4.33, −2.27)* < 0.001
Percent Reduction 83 / 66 −1.6 (−2.47, −0.73)* < 0.001
Cylinder Test 161 / 205 −2.42 (−3.17, −1.66)* < 0.001
Adhesive Removal Test
Use of paralyzed limb 69 / 62 1.17 (0.51, 1.84)* 0.001
Time to adhesive removal 67 / 49 −1.96 (−4.48, 0.56) 0.13
Neurological Deficit Score 74 / 74 −1.04 (−1.8, −0.27)* 0.008
Modified Neurological Deficit Score 48 / 48 −1.6 (−3.38, 0.18) 0.078

SMD: Standardized Mean Difference

*

SMD shows significantly favorable effect of BMMNC treatment